Pulmonary Artery Pressure

Two catheter-directed thrombectomy devices demonstrated efficacy and safety in the treatment of acute intermediate-risk pulmonary embolism, speakers reported.

Patients with HF who viewed their daily pulmonary artery pressure made informed lifestyle choices, decreased weight and improved their pressure, especially those above target range, a speaker reported.

Lower mean diastolic pulmonary artery pressure was associated with improvements in HF symptoms among participants in the EMBRACE-HF trial, researchers reported.

Despite significant improvements in care, HF remains a progressive, complex disease process associated with significant hospital admissions and cost.

First-in-human study of sensor (Cordella, Endotronix) to measure pulmonary artery pressure in patients with HF.

Use of CardioMEMS HF System (Abbott) in a real-world setting.

Pulmonary hypertension that occurs during exercise was found to be associated with poor CV event-free survival for patients with chronic dyspnea who show no signs of pulmonary hypertension at rest.

PHILADELPHIA — Omecamtiv mecarbil, a selective cardiac myosin activator, improved diastolic function and pulmonary pressures without worsening diastolic filling in patients with chronic HF and reduced systolic function, according to data presented at the American Heart Association Scientific Sessions.

PHILADELPHIA — Two different sensors were able to safety and accurately measure pulmonary artery pressures for remote HF management, which resulted in improvements in symptoms and quality of life, according to data from the SIRONA and MEMS-HF trials presented at the American Heart Association Scientific Sessions.